메뉴 건너뛰기




Volumn 23, Issue 1, 2003, Pages 129-137

Transmissible spongiform encephalopathy update and implications for blood safety

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD TRANSFUSION; CREUTZFELDT JAKOB DISEASE; HUMAN; MEDICAL PRACTICE; POLICY; PRION DISEASE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SAFETY;

EID: 0037366963     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-2712(02)00066-5     Document Type: Review
Times cited : (6)

References (32)
  • 1
    • 0032757723 scopus 로고    scopus 로고
    • Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans
    • Brown P, Cervanakova L, McShane LM, Barber P, Rubenstein R, Drohan WN. Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans. Transfusion 1999;39:1169-78.
    • (1999) Transfusion , vol.39 , pp. 1169-1178
    • Brown, P.1    Cervanakova, L.2    McShane, L.M.3    Barber, P.4    Rubenstein, R.5    Drohan, W.N.6
  • 2
    • 0342951746 scopus 로고    scopus 로고
    • A new variant of Creutzfeldt-Jakob disease in the UK
    • Will R, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996;347:921-5.
    • (1996) Lancet , vol.347 , pp. 921-925
    • Will, R.1    Ironside, J.W.2    Zeidler, M.3
  • 3
    • 0035820405 scopus 로고    scopus 로고
    • Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease
    • Brown P. Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease. BMJ 2001;322:841-4.
    • (2001) BMJ , vol.322 , pp. 841-844
    • Brown, P.1
  • 4
    • 0032612107 scopus 로고    scopus 로고
    • BSE: Transmission studies with particular reference to blood
    • Brown F, Cartwright T, Horaud F, Speiser JM, editors. Animal sera, animal sera derivatives and substitutes used in the manufacture of pharmaceuticals: viral safety and regulatory aspects
    • Bradley R. BSE: transmission studies with particular reference to blood. In: Brown F, Cartwright T, Horaud F, Speiser JM, editors. Animal sera, animal sera derivatives and substitutes used in the manufacture of pharmaceuticals: viral safety and regulatory aspects. Dev Biol (Basel) 1999;99:35-40.
    • (1999) Dev Biol (Basel) , vol.99 , pp. 35-40
    • Bradley, R.1
  • 6
    • 0020522298 scopus 로고
    • Creutzfeldt-Jakob disease in mice: Persistent viremia and preferential replication of virus in low-density lymphocytes
    • Kuroda Y, Gibbs CJ Jr, Amyx HL, Gajdusek DC. Creutzfeldt-Jakob disease in mice: persistent viremia and preferential replication of virus in low-density lymphocytes. Infect Immun 1983;41:154-61.
    • (1983) Infect Immun , vol.41 , pp. 154-161
    • Kuroda, Y.1    Gibbs C.J., Jr.2    Amyx, H.L.3    Gajdusek, D.C.4
  • 8
    • 3543092761 scopus 로고    scopus 로고
    • The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy
    • Brown P, Rohwer RG, Dunstan BS, MacAuley C, Gajdusek DC, Drohan WN. The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion 1998;38:810-6.
    • (1998) Transfusion , vol.38 , pp. 810-816
    • Brown, P.1    Rohwer, R.G.2    Dunstan, B.S.3    MacAuley, C.4    Gajdusek, D.C.5    Drohan, W.N.6
  • 9
    • 0033847725 scopus 로고    scopus 로고
    • Different levels of prion protein (PrPc) expression on hamster, mouse and human blood cells
    • Holada K, Vostal JG. Different levels of prion protein (PrPc) expression on hamster, mouse and human blood cells. Br J Haematol 2000;110:472-80.
    • (2000) Br J Haematol , vol.110 , pp. 472-480
    • Holada, K.1    Vostal, J.G.2
  • 10
    • 0035108652 scopus 로고    scopus 로고
    • The pathogenesis of transmissible spongiform encephalopathy: Routes to the brain and the erection of therapeutic barricades
    • Brown P. The pathogenesis of transmissible spongiform encephalopathy: routes to the brain and the erection of therapeutic barricades. Cell Mol Life Sci 2001;58:259-65.
    • (2001) Cell Mol Life Sci , vol.58 , pp. 259-265
    • Brown, P.1
  • 11
    • 0027447219 scopus 로고
    • Transmission of Creutzfeldt-Jakob disease by blood transfusion
    • Klein R, Duble LJ. Transmission of Creutzfeldt-Jakob disease by blood transfusion. Lancet 1993;341:205-7.
    • (1993) Lancet , vol.341 , pp. 205-207
    • Klein, R.1    Duble, L.J.2
  • 12
    • 0029125679 scopus 로고
    • Creutzfeldt-Jakob disease after liver transplantation
    • Créange A, Gray F, Cesaro P, et al. Creutzfeldt-Jakob disease after liver transplantation. Ann Neurol 1995;38:269-72.
    • (1995) Ann Neurol , vol.38 , pp. 269-272
    • Créange, A.1    Gray, F.2    Cesaro, P.3
  • 13
    • 0031747570 scopus 로고    scopus 로고
    • Creutzfeldt-Jakob disease (CJD) after blood product transfusion from a donor with CJD
    • Patry D, Curry B, Easton D, et al. Creutzfeldt-Jakob disease (CJD) after blood product transfusion from a donor with CJD. Neurology 1998;50:1872-3.
    • (1998) Neurology , vol.50 , pp. 1872-1873
    • Patry, D.1    Curry, B.2    Easton, D.3
  • 15
    • 0034237683 scopus 로고    scopus 로고
    • Risk of acquiring Creutzfeldt-Jakob disease from blood transfusions: Systematic review of case-control studies
    • Wilson K, Code C, Ricketts MN. Risk of acquiring Creutzfeldt-Jakob disease from blood transfusions: systematic review of case-control studies. BMJ 2000;321:17-9.
    • (2000) BMJ , vol.321 , pp. 17-19
    • Wilson, K.1    Code, C.2    Ricketts, M.N.3
  • 16
    • 0031682547 scopus 로고    scopus 로고
    • Surveillance for Creutzfeldt-Jakob disease among persons with haemophilia
    • Evatt B, Austin E, Barnhart L, et al. Surveillance for Creutzfeldt-Jakob disease among persons with haemophilia. Transfusion 1998;38:817-20.
    • (1998) Transfusion , vol.38 , pp. 817-820
    • Evatt, B.1    Austin, E.2    Barnhart, L.3
  • 17
    • 0031766582 scopus 로고    scopus 로고
    • Retrospective neuropathological review of prion disease in UK haemophiliac patients
    • Lee CA, Ironside JW, Bell JE, et al. Retrospective neuropathological review of prion disease in UK haemophiliac patients. Thromb Haemost 1998;80:909-11.
    • (1998) Thromb Haemost , vol.80 , pp. 909-911
    • Lee, C.A.1    Ironside, J.W.2    Bell, J.E.3
  • 18
    • 0028128111 scopus 로고
    • Creutzfeldt-Jakob disease and blood transfusion
    • Heye N, Hensen S, Muller N. Creutzfeldt-Jakob disease and blood transfusion. Lancet 1994;343:298-9.
    • (1994) Lancet , vol.343 , pp. 298-299
    • Heye, N.1    Hensen, S.2    Muller, N.3
  • 19
    • 0028879731 scopus 로고
    • Pooled plasma derivatives and Creutzfeldt-Jakob disease
    • Operskalski EA, Mosley JW. Pooled plasma derivatives and Creutzfeldt-Jakob disease. Lancet 1995;346:1224.
    • (1995) Lancet , vol.346 , pp. 1224
    • Operskalski, E.A.1    Mosley, J.W.2
  • 21
    • 0033855746 scopus 로고    scopus 로고
    • European surveillance on Creutzfeldt-Jakob disease: A case-control study for medical risk factors
    • Zerr I, Brandel J-P, Masullo C, et al. European surveillance on Creutzfeldt-Jakob disease: a case-control study for medical risk factors. J Clin Epidemiol 2000;53:747-54.
    • (2000) J Clin Epidemiol , vol.53 , pp. 747-754
    • Zerr, I.1    Brandel, J.-P.2    Masullo, C.3
  • 22
    • 0030255674 scopus 로고    scopus 로고
    • Creutzfeldt-Jakob disease in the United States, 1979-1994: Using national mortality data to assess the possible occurrence of variant cases
    • Holman RC, Khan AS, Belay ED, Schonberger LB. Creutzfeldt-Jakob disease in the United States, 1979-1994: using national mortality data to assess the possible occurrence of variant cases. Emerg Infect Dis 1996;2:333-7.
    • (1996) Emerg Infect Dis , vol.2 , pp. 333-337
    • Holman, R.C.1    Khan, A.S.2    Belay, E.D.3    Schonberger, L.B.4
  • 23
    • 0031735778 scopus 로고    scopus 로고
    • Creutzfeldt-Jakob disease and the risk from blood or blood products
    • Will RG, Kimberlin RH. Creutzfeldt-Jakob disease and the risk from blood or blood products. Vox Sang 1998;75:178-80.
    • (1998) Vox Sang , vol.75 , pp. 178-180
    • Will, R.G.1    Kimberlin, R.H.2
  • 24
    • 85031181999 scopus 로고    scopus 로고
    • Report on the safety of ruminant blood with respect to TSE risks
    • Paper presented, Brussels, Germany, April 13-14
    • Budka H, Pocchiari M, Aguzzi A, et al. Report on the safety of ruminant blood with respect to TSE risks, Paper presented at the meeting of the Scientific Steering Committee, Brussels, Germany, April 13-14, 2000.
    • (2000) Meeting of the Scientific Steering Committee
    • Budka, H.1    Pocchiari, M.2    Aguzzi, A.3
  • 25
    • 0032578283 scopus 로고    scopus 로고
    • Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease
    • Hilton DA, Fathers E, Edwards P, Ironside JW, Zajicek J. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 1998;352:703-4.
    • (1998) Lancet , vol.352 , pp. 703-704
    • Hilton, D.A.1    Fathers, E.2    Edwards, P.3    Ironside, J.W.4    Zajicek, J.5
  • 26
    • 0033573778 scopus 로고    scopus 로고
    • Investigation of variant Creutzfeldt-Jakob and other human prion diseases with tonsil biopsy samples
    • Hill AF, Butterworth RJ, Jointer S, et al. Investigation of variant Creutzfeldt-Jakob and other human prion diseases with tonsil biopsy samples. Lancet 1999;353:183-99.
    • (1999) Lancet , vol.353 , pp. 183-199
    • Hill, A.F.1    Butterworth, R.J.2    Jointer, S.3
  • 27
    • 0035957401 scopus 로고    scopus 로고
    • Adaptation of the BSE agent to primates and comparison with Creutzfeldt-Jakob disease: Implications for human health
    • Lazmézas CI, Fournier J-G, Nouvel V, et al. Adaptation of the BSE agent to primates and comparison with Creutzfeldt-Jakob disease: implications for human health. Proc Natl Acad Sci USA 2001;98:4142-7.
    • (2001) Proc Natl Acad Sci USA , vol.98 , pp. 4142-4147
    • Lazmézas, C.I.1    Fournier, J.-G.2    Nouvel, V.3
  • 28
    • 1642521478 scopus 로고    scopus 로고
    • Delay in plasma replacement
    • Warden J. Delay in plasma replacement. BMJ 1998;317:1409.
    • (1998) BMJ , vol.317 , pp. 1409
    • Warden, J.1
  • 29
    • 0030771006 scopus 로고    scopus 로고
    • Potential increased risk of virus transmission due to exclusion of older donors because of concern over Creutzfeldt-Jakob disease. The National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study
    • Busch MP, Glynn SA, Schreiber GB. Potential increased risk of virus transmission due to exclusion of older donors because of concern over Creutzfeldt-Jakob disease. The National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study. Transfusion 1997; 37:996-1002.
    • (1997) Transfusion , vol.37 , pp. 996-1002
    • Busch, M.P.1    Glynn, S.A.2    Schreiber, G.B.3
  • 30
    • 0034711323 scopus 로고    scopus 로고
    • Variant Creutzfeldt-Jakob disease (vCJD): Precautionary measures against the risk of transmission of the agent of vCJD by blood transfusion
    • World Health Organization. Variant Creutzfeldt-Jakob disease (vCJD): precautionary measures against the risk of transmission of the agent of vCJD by blood transfusion. Weekly Epidemiologic Record No. 47, 2000;75:377-8.
    • (2000) Weekly Epidemiologic Record No. 47 , vol.75 , pp. 377-378
  • 31
    • 0034711176 scopus 로고    scopus 로고
    • Iatrogenic CJD at the millennium
    • Brown P, Preece M, Brandel J-P, et al. Iatrogenic CJD at the millennium. Neurology 2000;55:1075-81.
    • (2000) Neurology , vol.55 , pp. 1075-1081
    • Brown, P.1    Preece, M.2    Brandel, J.-P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.